US 7,557,135 B2
	Inhibitors of cytosolic phospholipase A2
John C. McKew, Arlington, Mass. (US); Katherine L. Lee, Newton, Mass. (US); Lihren Chen, Bedford, Mass. (US); Richard Vargas, Brighton, Mass. (US); James D. Clark, Acton, Mass. (US); Cara Williams, Methuen, Mass. (US); Valerie Clerin, Watertown, Mass. (US); Suzana Marusic, Reading, Mass. (US); and Kevin Pong, Robbinsville, N.J. (US)
Assigned to Wyeth, Madison, N.J. (US)
Filed on May 26, 2006, as Appl. No. 11/442,199.
Claims priority of provisional application 60/685564, filed on May 27, 2005.
Prior Publication US 2007/0004719 A1, Jan. 04, 2007
Int. Cl. A61K 31/404 (2006.01); C07D 209/14 (2006.01)

U.S. Cl. 514—415  [548/507]

2 Claims

1. 3-{4-[(2-{5-chloro-1-(diphenylmethyl)-2-[2-({[2-(trifluoromethyl)benzyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethyl)sulfonyl]phenyl}propanoic acid, or a pharmaceutically acceptable salt thereof.